CLINICAL_TRIALS
trial_result
· 2018-04-11
Clinical Trial Update: KJ-TFC-004 Drug-drug Interaction Study [Phase 1]
Summary
Phase 1 study evaluating drug-drug interactions for KJ-TFC-004 in glaucoma and ocular hypertension has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kukje Pharma | Conditions: Glaucoma, Eye Diseases | Phase 1 | Status: COMPLETED